Go to main content | Go to main menu | Go to search

Horizon Europe

Horizon Europe – open calls and other preliminary deadlines


I.pillar

ERC
  • Synergy grant
  • Proof of concept
MSCA
  • Doctoral Networks
    MSCA-DN-2021, opening 4/5/2021, DDL 16/11/2021
    MSCA-DN-2022, opening 3/5/2022, DDL 15/11/2022
  • Postdoctoral Fellowships
    MSCA-PF-2021, opening 15/4/2021, DDL 15/9/2021
    MSCA-PF-2022, opening 14/4/2022, DDL 14/9/2022
  • Staff Exchanges
    MSCA-SE-2021, opening 7/10/2021, DDL 9/3/2022
    MSCA-SE-2022, opening 6/10/2022, DDL 8/3/2023
  • MSCA COFUND
    MSCA-COFUND-2021, opening 12/10/2021, DDL 10/2/2022
    MSCA-COFUND-2022, opening 11/10/2022, DDL 9/2/2023
  • MSCA and Citizens
    MSCA-CITIZENS-2022, opening 17/6/2021, DDL 7/10/2021
Research infrastructures

n/a

II.pillar

Cluster Health

Staying healthy 2021, opening ______, DDL 21/9/2021
  • HORIZON-HLTH-2021-STAYHLTH-01-02: Towards a molecular and neurobiological understanding of mental health and mental illness for the benefit of citizens and patients
  • HORIZON-HLTH-2021-STAYHLTH-01-03: Supporting digital empowerment and health literacy – Healthy citizens 2.0
  • HORIZON-HLTH-2021-STAYHLTH-01-04: A roadmap for personalised prevention
  • HORIZON-HLTH-2021-STAYHLTH-01-05: Mobilising the network of National Contact Points in the Health Cluster
Staying healthy 2022 , opening 6/10/2021 , DDL 1/2/2022 (first stage) 6/9/2022 (second stage)
  • HORIZON-HLTH-2022-STAYHLTH-01-01-two-stage: Boosting mental Health in Europe in times of change
  • HORIZON-HLTH-2022-STAYHLTH-01-04-two-stage: Trustworthy AI tools to predict the risk of chronic non-communicable diseases and/or their progression
  • HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage: Prevention of obesity through the life course
  • HORIZON-HLTH-2022-STAYHLTH-02-01: Personalised blue print of chronic inflammation in health-to-disease transition (single stage, opening 6/10/2021, DDL 21/4/2022)
Environment and health (2021), opening 22/4/2021, DDL 21/9/2021
  • HORIZON-HLTH-2021-ENVHLTH-02-01: Exposure to electromagnetic fields (EMF)and health
  • HORIZON-HLTH-2021-ENVHLTH-02-02: Indoor air quality and health
  • HORIZON-HLTH-2021-ENVHLTH-02-03: Health impacts of climate change, costs and benefits of action and inaction
Partnerships in Health (2021), opening 22/4/2021, DDL 21/9/2021
  • HORIZON-HLTH-2021-ENVHLTH-03-01: European Partnership for the Assessment of Risks from Chemicals (PARC)
Environment and health (Single Stage - 2022), opening 6/10/2021, DDL 21/4/2022
  • HORIZON-HLTH-2022-ENVHLTH-04-01: Methods for assessing health-related costs to environmental stressors
Tackling diseases (2021), opening 22/4/2021, DDL 21/9/2021
  • HORIZON-HLTH-2021-DISEASE-04-01: Towards improved supportive, palliative,survivorship and end-of-life care of cancer patients
  • HORIZON-HLTH-2021-DISEASE-04-02: Building a European innovation platform for the repurposing of medicinal products
  • HORIZON-HLTH-2021-DISEASE-04-03: Innovative approaches to enhance povertyrelated diseases research in sub-Saharan Africa
  • HORIZON-HLTH-2021-DISEASE-04-04: Clinical validation of artificial intelligence solutions for treatment and care
  • HORIZON-HLTH-2021-DISEASE-04-07: Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g., SARS-CoV-2)
  • HORIZON-HLTH-2021-DISEASE-04-05: A roadmap towards the creation of the European One Health antimicrobial resistance partnership (OH AMR)
  • HORIZON-HLTH-2021-DISEASE-04-06: Building a European Research and Innovation Partnership for Pandemic Preparedness
Tackling diseases (Two Stage - 2022), opening 6/10/2021, DDL 1/2/2022 (first stage), 6/9/2022 (second stage)
  • HORIZON-HLTH-2022-DISEASE-06-02-two-stage: Pre-clinical development of the next generation immunotherapies for diseases or disorders with unmet medical need
  • HORIZON-HLTH-2022-DISEASE-06-03-two-stage: Vaccines 2.0 - developing the next generation of vaccines
  • HORIZON-HLTH-2022-DISEASE-06-04-two-stage: Development of new effective therapies for rare diseases
Tackling diseases (Single Stage - 2022), opening 6/10/2021, DDL 21/4/2022
  • HORIZON-HLTH-2022-DISEASE-07-02: Pandemic Preparedness – Placeholder
  • HORIZON-HLTH-2022-DISEASE-07-03: Non-communicable diseases risk reduction in adolescence and youth
  • HORIZON-HLTH-2022-DISEASE-07-01: GloPID R secretariat – Placeholder
Partnerships in Health (2022), opening 6/10/2021, DDL 21/4/2022
  • HORIZON-HLTH-2022-DISEASE-03-01: European Partnership Fostering an ERA for Health research – Placeholder
Ensuring access to innovative, sustainable and high-quality health care (2021), opening 22/4/2021, DDL 21/9/2021
  • HORIZON-HLTH-2021-CARE-05-01: Enhancing quality of care and patient safety
  • HORIZON-HLTH-2021-CARE-05-02: Data-driven decision-support tools for better health and care delivery and policy-making
  • HORIZON-HLTH-2021-CARE-05-04: Health and care innovation procurement network
Ensuring access to innovative, sustainable and high-quality health care (Single Stage - 2022), opening 6/10/2021, DDL 21/4/2022
  • HORIZON-HLTH-2022-CARE-08-02: Innovation procurement (PCP) for building the resilience of health and care systems in the context of recovery
  • HORIZON-HLTH-2022-CARE-08-03: Innovation procurement (PPI) for building the resilience of health and care systems in the context of recovery
  • HORIZON-HLTH-2022-CARE-08-04: Better economic foresight, financial planning and procurement/contractual strategies for health systems
Partnerships in Health (2022), opening 6/10/2021, DDL 21/4/2022
  • HORIZON-HLTH-2022-CARE-10-01: European Partnership on Transforming Health and Care Systems
Tools and technologies for a healthy society (2021), opening 22/4/2021, DDL 21/9/2021
  • HORIZON-HLTH-2021-TOOL-06-01: Smart medical devices and their surgical implantation for use in resource-constrained settings
  • HORIZON-HLTH-2021-TOOL-06-02: Next generation advanced therapies to treat highly prevalent and high burden diseases with unmet needs
  • HORIZON-HLTH-2021-TOOL-06-03: Innovative tools for use and re-use of health data (in particular electronic health records and/or patient registries)
Tools and technologies for a healthy society (Single Stage - 2022), opening 6/10/2021, DDL 21/4/2022
  • HORIZON-HLTH-2022-TOOL-11-01: Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers
  • HORIZON-HLTH-2022-TOOL-11-02: New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment
Tools and technologies for a healthy society (2022), opening 6/10/2021, DDL21/4/2022
  • HORIZON-HLTH-2022-TOOL-12-01-two-stage: Computational models for new patient stratification strategies
A competitive health-related industry (2021), opening 22/4/2021, DDL 21/9/2021
  • HORIZON-HLTH-2021-IND-07-01: Green pharmaceuticals
  • HORIZON-HLTH-2021-IND-07-02: Development procurement and responsible management of new antimicrobials
  • HORIZON-HLTH-2021-IND-07-03: Promoting a trusted mHealth label in Europe: uptake of Technical specifications for “Quality and Reliability of Health and Wellness Apps”
A competitive health-related industry (2022), opening 6/10/2021, DDL 21/4/2022
  • HORIZON-HLTH-2022-IND-13-01: Enhancing Cybersecurity of connected Medical Devices
  • HORIZON-HLTH-2022-IND-13-02: Scaling up multi-party computation, data anonymisation techniques and synthetic data generation
  • HORIZON-HLTH-2022-IND-13-03: New payment models for cost-effective and affordable health innovations/new models of pricing
  • HORIZON-HLTH-2022-IND-13-04: Setting up a European Smart Health Innovation Hub
  • HORIZON-HLTH-2022-IND-13-05: Setting up a European Electronic Health Record Exchange Format Ecosystem
III.pillar
EIC
  • EIC Pathfinder Open, DDL 19/5/2021
  • EIC Pathfinder Challenge, DDL 27/10/2021
  • EIC Transition Open, DDL 22/9/2021
  • EIC Transition Challenge
  • EIC Accelerator, DDL 9/6/2021, DDL 6/10/2021
EIE
  • CONNECT, n/a
  • SCALEUP, n/a
  • INNOVSMES, n/a
EIT
  • EIT Food: řešení udržitelného dodavatelského řetězce od zdrojů ke spotřebitelům
    https://www.eitfood.eu/
HORIZON PRIORITIES - WIDENING
Teaming
  • HORIZON-WIDERA-2022-ACCESS-01-01-two-stage: Teaming for Excellence, opening 11/5/2021, 9/9/2021 (first stage evaluation), 20/4/2022 (second stage evaluation)
Twinning
  • HORIZON-WIDERA-2021-ACCESS-03-01: Twinning, opening 15/ 6/2021, DDL 21/ 2/2021
  • HORIZON-WIDERA-2021-ACCESS-02-01: Twinning Western Balkans, opening 20/4/ 2021, DDL 22/9/2021
Excellence Hubs
  • HORIZON-WIDERA-2022-ACCESS-04-01: Excellence Hubs, opening 3/11/20210, DDL 15/3/2022
Hop-on-facility
  • HORIZON-WIDERA-2022-HOPON-01-01: Hop On Facility, opening 4/1/2022, DDL 20/4/2022 a 10/11/2022
Strengthening capacity for excellence in universities and surrounding ecosystems
  • HORIZON-WIDERA-2021-ACCESS-05-01: European Excellence Initiative (EEI), opening 9/6/ 2021, DDL 4/11/2021
ERA-Chair
  • HORIZON-WIDERA-2022-TALENTS-01-01: ERA Chairs, opening 8/6/2021, DDL 15/3/2022
Talents, mobility
  • HORIZON-WIDERA-2022-TALENTS-02-01: ERA Fellowships, opening 15/4/2021, DDL 15/9/2021
  • HORIZON-WIDERA-2022-TALENTS-04-01: ERA Fellowships, opening 14/4/2022, DDL 15/9/2022
  • HORIZON-WIDERA-2022-TALENTS-03-01: ERA Talents, opening 1/12/2021, DDL 12/4/2022


Contact::

JUDr. Sabina Krejčiříková
tel.: +420 773 774 204
mail: krejcirikovas@pharm.muni.cz

Marie Skłodowska-Curie Actions

Jak získat financování pro postdoky?

We would like to introduce the Marie Sklodowska-Curie Actions (MSCA), a European Union programme that provides funding for postdocs in the form of 2-year fellowships.

With other programmes linked to the application, the chance of obtaining the funding is very realistic.

Therefore, we would like to introduce you to the possibilities offered by the MSCA programme and support you in your application!

 

What is the essence of the MSCA? 

The essence of the MSCA Postdoctoral Fellowship (MSCA-PF) is to support the all-round professional and career development of young scientists.

The basis of the application is a high quality scientific proposal and the development of the postdoc's professional skills under the guidance of an experienced supervisor, whose role is very important both in the writing of the proposal and in the implementation of the project.

However, it is also important to have a career development plan for the postdocs in other areas such as intellectual property, open science, publication strategy, group management and communication of scientific results to the professional and lay public. The Project Support can assist you in developing a plan kaMSCA-PF, which is designed for postdocs who are changing location and transferring or have recently transferred to another institution.

 

Who can propose of the MSCA Postdoctoral Fellowship?

The MSCA-PF is designed for postdocs who are changing locations and are transferring or have recently transferred to another institution.

The applicant must meet the following conditions:

  • defence of their PhD no later than the deadline date
  • the applicant can be no longer than 8 years after obtaining the PhD degree
  • spent a maximum of 12 months in the Czech Republic in the last 3 years (short-term stays e.g. as a family visit do not count, it should be active pursuit of science/PhD studies outside the Czech Republic; counted towards the application deadline)

Practical: If you are recruiting a postdoc coming from abroad, we recommend that you always check whether they are eligible to apply for MSCA-PF! (This also applies to postdocs already recruited with a contract after 15 September 2020)

What fellowship offer?

The MSCA-PF offers funding for the postdoc's salary and also it also provides them with an allowance for their family and material expenses for 2 years:

What are the chances of getting a fellowship?

MSCA-PF is a highly competitive contest. For a postdoc to qualify for direct support from the MSCA-PF programme, their proposal must normally score around 93 %, which is achieved by 10–15 % of applicants.

But in addition to this basic competition, there are two other "sub-competitions" that you can enter, which provide the same level of support:

  • ERA Fellowship (formerly Widening Fellowship) – for postdocs in selected countries, including the Czech Republic, additional support is allocated to accommodate a larger number of applicants. The required score is approximately 90%. Approximately 20–30% of applicants are in the 90%–100% range.
  • MŠMT OP JAK – a programme announced by the MŠMT for applicants who have not been awarded the MSCA-PF, but whose proposal has been assessed as of high quality (so far the rating of 70% and above, which is surpassed by approximately 70–80% of applicants. For the first time, this call will be announced with a time gap, but the probability of success in receiving this support is very high (the 70% threshold will be officially confirmed after the announcement of this year's MSCA-PF call on 15 April 2021).

The level of the evaluation depends on the quality of the scientific proposal and career plan, the quality of the applicant and the supervisor, but approximately 90% of applications at MUNI have been evaluated above 70% in recent years and these applications are therefore eligible to apply for support from the Ministry of Education and Science.

 

What are the dates?

  • MSCA-PF call launch: 15 April 2021
  • Deadline for submission of applications: 15 September 2021
  • Announcement of results: February 2022
  • Expected start of MSCA-PF projects: June 2022 (delays of up to 1.5 years can be negotiated)
  • Announcement of the call of the Ministry of Education and Science OP JAK: spring 2022
  • Start of projects supported by JAK OP: January 2023

 

Tip!: Become an evaluator of MSCA-PF proposals and gain valuable experience

In addition to new MSCA-PF applicants, we are also looking for experienced scientists who would be interested in becoming internal reviewers for upcoming applications or directly become official MSCA-PF evaluators.

If you are interested in joining an internal group of scientists who are willing to review proposal concepts and give feedback to postdocs, please contact Jakub Zeman at zeman@rect.muni.cz.

If you are interested in becoming an official reviewer, you can find more information at this link:

https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/work-as-an-expert

Both options will definitely give you an interesting experience.

 

Where to get more information?

We invite you to attend an online seminar to find out more detailed information.

The seminar will take place on 28 April 2021 from 9.00-11.00 a.m. and is primarily for postdocs and their supervisors.

Workshops are then planned for postdocs and their supervisors during the spring/summer to learn more about the content and format of the MSCA-PF application.

REGISTRATION FOR THE WORKSHOP

 

Who and how will help you with the application process?

  • Mgr. Jakub Zeman - zeman@rect.muni.cz - Chief MSCA Coordinator at MU
  • JUDr. Sabina Krejčiříková - krejcirikovas@pharm.muni.cz

We will help you check your eligibility to apply for MSCA-PF and with writing the full proposal. Do not hesitate to contact us - the sooner the better!

You are running an old browser version. We recommend updating your browser to its latest version.

More info